CausalSentinel

Protein Dossier — PON1 (Serum paraoxonase/arylesterase 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Body mass index (BMI) 0.00803 0.00312 0.00996 Wald ratio 1 cis NA
Lung cancer -0.0545 0.0222 0.0139 Wald ratio 1 cis NA
Diagnoses - main ICD10: R04 Haemorrhage from respiratory passages 0.0898 0.0397 0.0235 Wald ratio 1 cis NA
Non-cancer illness code self-reported: joint disorder -0.113 0.0511 0.0275 Wald ratio 1 cis NA
Underlying (primary) cause of death: ICD10: E85.4 Organ-limited amyloidosis 0.797 0.364 0.0284 Wald ratio 1 cis NA
Diagnoses - main ICD10: K20 Oesophagitis 0.0608 0.0296 0.0401 Wald ratio 1 cis NA
Diagnoses - main ICD10: J33 Nasal polyp 0.0844 0.0417 0.0428 Wald ratio 1 cis NA
Non-cancer illness code self-reported: bone disorder 0.12 0.0592 0.0429 Wald ratio 1 cis NA
Age at menopause -0.0471 0.0236 0.0455 Wald ratio 1 cis NA
Non-cancer illness code self-reported: kidney stone or ureter stone or bladder stone 0.0657 0.033 0.0465 Wald ratio 1 cis NA
Weight 0.00536 0.00275 0.0514 Wald ratio 1 cis NA
Fractured bone site(s): Wrist -0.0454 0.0233 0.0514 Wald ratio 1 cis NA
…and 104 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4261_55_2 paraoxonase 1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

254 association rows across 190 traits (248 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating PON3 levels 2e-891 rs10953142 1 GCST90859987 no MR -> candidate analysis
Testis-expressed sequence 29 protein levels 4e-400 rs662 2 GCST90249809 no MR -> candidate analysis
Myeloid leukemia factor 1 levels 3e-316 rs3917529 1 GCST90248481 no MR -> candidate analysis
Paraoxonase activity 1e-303 rs2057681 2 GCST001677 no MR -> candidate analysis
PON1 protein levels 2e-215 rs705379 13 GCST90453213 no MR -> candidate analysis
Proteasome subunit beta type-9 levels 6e-148 rs1157745 2 GCST90249140 no MR -> candidate analysis
T-cell surface protein tactile levels 1e-99 rs1157745 2 GCST90249758 no MR -> candidate analysis
Syntaxin-10 levels (STX10.12842.43.3) 1e-93 rs662 1 GCST90242944 no MR -> candidate analysis
Testis-expressed sequence 29 protein levels (TEX29.10557.6.3 3e-93 rs3917539 2 GCST90242989 no MR -> candidate analysis
Filamin-A level in Chronic kidney disease with hypertension 6e-81 rs662 1 GCST90233147 no MR -> candidate analysis
PON2 protein levels 2e-79 rs3917510 3 GCST90470286 no MR -> candidate analysis
NHL repeat-containing protein 3 levels 3e-79 rs1157745 1 GCST90248677 no MR -> candidate analysis
…and 178 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 795 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
amyotrophic lateral sclerosis 0.525 established (curated) no MR -> candidate analysis
atopic eczema 0.554 common-variant locus no MR -> candidate analysis
obesity disorder 0.475 common-variant locus no MR -> candidate analysis
idiopathic pulmonary fibrosis 0.388 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.057 common-variant locus no MR -> candidate analysis
diabetes mellitus 0.057 common-variant locus no MR -> candidate analysis

Of the 6 rows above, 6 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Serum paraoxonase/arylesterase 1)
gnomAD constraint pLI=1.5e-12, LOEUF=1.24 — LoF-tolerant
GWAS Catalog 120 unique SNPs / 251 rows
ClinVar 97 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance